tetravac injektionsvæske, suspension
sanofi pasteur europe - bordetella pertussis, filamentøs hæmagglutinin (fha), bordetella pertussis, toxoid, clostridium tetani, stamme harvard 49205, toxoid, corynebacterium diphtheria, stamme utrecht cn 2000 msm iii, toxoid, poliovirus type 1, stamme mahoney (inaktiveret), poliovirus type 2, stamme mef-1 (inaktiveret), poliovirus type 3, stamme saukett (inaktiveret) - injektionsvæske, suspension
vepicombin novum 85.000 ie/ml granulat til oral opløsning
takeda pharma a/s - phenoxymethylpenicillinkalium - granulat til oral opløsning - 85.000 ie/ml
zantac 300 mg brusetabletter
paranova danmark a/s - ranitidinhydrochlorid - brusetabletter - 300 mg
zarator 10 mg tyggetabletter
upjohn eesv - atorvastatincalcium (trihydrat) - tyggetabletter - 10 mg
zarator 20 mg tyggetabletter
upjohn eesv - atorvastatincalcium (trihydrat) - tyggetabletter - 20 mg
zofran 4 mg frysetørret tablet
sandoz a/s - ondansetron - frysetørret tablet - 4 mg
zofran zydis 4 mg frysetørret tablet
2care4 aps - ondansetron - frysetørret tablet - 4 mg
colestyramin "orifarm" 4 g pulver til oral suspension, enkeltdosisbeholder
orifarm generics a/s - colestyramin - pulver til oral suspension, enkeltdosisbeholder - 4 g
dengvaxia
sanofi pasteur - chimeric yellow fever dengue virus serotype 1 (live, attenuated), chimeric yellow fever dengue virus serotype 2 (live, attenuated), chimeric yellow fever dengue virus serotype 3 (live, attenuated), chimeric yellow fever dengue virus serotype 4 (live, attenuated) - dengue - vacciner - dengvaxia is indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 6 to 45 years of age with test-confirmed previous dengue infection (see sections 4. 2, 4. 4 og 4. brug af dengvaxia bør være i overensstemmelse med de officielle anbefalinger.
farpenta 5 mg smeltetabletter
rivopharm limited - olanzapin - smeltetabletter - 5 mg